Santarus Inc. (SNTS) and Pharming Group (PHGUF.PK) Announce FDA Acceptance for Review of RUCONEST (Recombinant Human C1 Esterase Inhibitor) Biologics License Application
More...
|
Immune Response BioPharma to Seek Approval of REMUNE With MCC of South Africa
More...
|
IntelGenx Corp. Announces FDA Acceptance of New Drug Application for Anti-Migraine VersaFilm™ Oral Film Product
More...
|
RedHill Biopharma Ltd. (RDHL) Announces FDA Acceptance for Review of RHB-103 NDA for Acute Migraine and PDUFA Goal Date of February 3, 2014
More...
|
Hyperion Therapeutics Announces RAVICTI and BUPHENYL Pharmacokinetic Analyses Reported in The Journal of Clinical Pharmacology
More...
|
Vanda Pharmaceuticals, Inc. (VNDA) Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm in Blind Patients With Non-24-Hour Disorder
More...
|
Ipsen (IPN.PA) Release: "PRIMARYS" Study Investigators Observed Clinically Relevant Results in an Investigational Phase III Study With Somatuline® Autogel® 120 mg in Patients With Acromegaly
More...
|
Adamas Pharmaceuticals Presents Positive Phase 2/3 Results for ADS-5102 for the Treatment of Levodopa-Induced Dyskinesia (LID) in Parkinson's Disease
More...
|
OncoSec Medical Inc. Announces Completion of Enrollment of Phase II Metastatic Melanoma Trial
More...
|
TWi Biotechnology Announces Completion of Patient Enrollment in Gout Flare Prophylaxis Phase II Trial for AC-201
More...
|
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Initiates Phase II Clinical Trial of Pracinostat and Vidaza® in Frontline Myelodysplastic Syndrome
More...
|
iCo Therapeutics Inc. Announces Completion of Trial Enrollment and Clinical Update for iDEAL Phase 2 Study for the Treatment of Diabetic Macular Edema
More...
|
DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus
More...
|
PhaseBio Pharmaceuticals, Inc. Expands Clinical Development of Vasomera, an Investigational Treatment for Cardiopulmonary Diseases
More...
|
Vaxil Reports Promising Results From Its Follow-Up Clinical Trial of ImMucin in Multiple Myeloma a Patients
More...
|
Sanford-Burnham Medical Research Institute Researchers Develop Novel Drug That Reverses Loss of Brain Connections in Models of Alzheimer's
More...
|
Isotechnika Pharma Inc. (ISA.TO) Receives Additional Funding From the Government of Canada for the Preclinical Development of NICAM 440-02 as an Anti-Hepatitis C Agent
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Multiple Presentations of Data from Phase III Pimavanserin Program at the 17th International Congress of Parkinson’s Disease and Movement Disorders
More...
|